(GBIO) – Company Press Releases
-
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
-
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
-
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
-
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
-
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
-
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms
-
Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results
-
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform
-
Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA
-
Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit
-
Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit
-
Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Generation Bio Reports Second Quarter 2023 Financial Results
-
Generation Bio to Present at the 2023 Jefferies Healthcare Conference
-
Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results
-
Generation Bio to Present at the JMP Securities Life Sciences Conference
-
Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
-
Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
-
Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer
-
Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer
-
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
-
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
-
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
-
Generation Bio to Participate in the BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines
-
Generation Bio to Participate in the BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines
-
Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference
-
Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference
-
Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results
-
Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results
-
Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
-
Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
-
Generation Bio Reports Business Highlights and Third Quarter 2022 Financial Results
-
Generation Bio Reports Business Highlights and Third Quarter 2022 Financial Results
-
Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit
-
Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit
-
Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer
-
Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer
-
Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results
-
Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results
-
Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference
-
Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference
-
Generation Bio Appoints Dannielle Appelhans to Its Board of Directors
-
Generation Bio Appoints Dannielle Appelhans to Its Board of Directors
-
Generation Bio Announces Update to Its GMP Manufacturing Strategy
-
Generation Bio Announces Update to Its GMP Manufacturing Strategy
-
Generation Bio to Present at the 2022 Jefferies Healthcare Conference
-
Generation Bio to Present at the 2022 Jefferies Healthcare Conference
-
Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results
-
Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results
Back to GBIO Stock Lookup
